Community Milestones
High Point University graduate student, Johnathon Friar, was recognized by the North Carolina High School Athletic Association with a Life Saver Certificate.
Stay updated with breaking news from Exact Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
High Point University graduate student, Johnathon Friar, was recognized by the North Carolina High School Athletic Association with a Life Saver Certificate.
Exact Sciences Applauds Final Task Force Recommendation That Lowers Starting Age for Colorectal Cancer Screening to 45 National Task Force supports Cologuard® as a screening option and screening expands to an additional ˜19 million Americans News provided by Share this article Share this article MADISON, Wis., May 18, 2021 /PRNewswire/ -- The United States Preventive Services Task Force (USPSTF) today released its final colorectal cancer screening recommendation that screening begin at age 45. Exact Sciences' (NASDAQ: EXAS) Cologuard ®, referred to as sDNA-FIT, is included as a recommended...
Message : Required fields Exact Sciences Applauds Final Task Force Recommendation That Lowers Starting Age for Colorectal Cancer Screening to 45 National Task Force supports Cologuard ® as a screening option and screening expands to an additional ˜19 million Americans MADISON, Wis.- May 18, 2021 - The United States Preventive Services Task Force (USPSTF) today released its final colorectal cancer screening recommendationthat screening begin at age 45. Exact Sciences' (NASDAQ: EXAS) Cologuard ®, referred to as sDNA-FIT, is included as a recommended screening option for all average-r...
Dive Brief: NeoGenomics has exercised its option to buy the remaining stake in Inivata for $390 million, positioning it to challenge for the liquid biopsy market. NeoGenomics expects the deal to close in the midlle of June. The takeover will give NeoGenomics full ownership of InVisionFirst-Lung, a lung cancer panel that it already commercializes in the U.S., and the residual disease assay RaDaR. William Blair analysts welcomed the deal, noting that NeoGenomics got a good price by setting the buyout fee when it invested $25 million in Inivata last year. Dive Insight: Inivata is a University o...
/PRNewswire/ -- The Liquid Biopsy for Cancer Diagnostics Competitive Landscape and Pipeline report is expected to rise due to an increased prevalence rate of...